nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—CYSLTR2—cardiovascular system—atherosclerosis	0.0179	0.208	CbGeAlD
Nedocromil—Sensation of warmth—Niacin—atherosclerosis	0.0178	0.0497	CcSEcCtD
Nedocromil—HSP90AA1—endothelium—atherosclerosis	0.0142	0.165	CbGeAlD
Nedocromil—PTGDR—adipose tissue—atherosclerosis	0.0134	0.156	CbGeAlD
Nedocromil—HSP90AA1—blood vessel—atherosclerosis	0.0131	0.153	CbGeAlD
Nedocromil—Cough increased—Rosuvastatin—atherosclerosis	0.00718	0.0201	CcSEcCtD
Nedocromil—HSP90AA1—connective tissue—atherosclerosis	0.00673	0.0782	CbGeAlD
Nedocromil—Feeling hot—Niacin—atherosclerosis	0.00609	0.017	CcSEcCtD
Nedocromil—Viral infection—Ezetimibe—atherosclerosis	0.00605	0.0169	CcSEcCtD
Nedocromil—CYSLTR1—adipose tissue—atherosclerosis	0.00595	0.0692	CbGeAlD
Nedocromil—HSP90AA1—cardiovascular system—atherosclerosis	0.00586	0.0681	CbGeAlD
Nedocromil—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00538	0.015	CcSEcCtD
Nedocromil—Cough increased—Niacin—atherosclerosis	0.00522	0.0146	CcSEcCtD
Nedocromil—Viral infection—Pravastatin—atherosclerosis	0.00521	0.0146	CcSEcCtD
Nedocromil—HSP90AA1—adipose tissue—atherosclerosis	0.00517	0.06	CbGeAlD
Nedocromil—Eczema—Simvastatin—atherosclerosis	0.00421	0.0118	CcSEcCtD
Nedocromil—Arthritis—Lovastatin—atherosclerosis	0.00416	0.0116	CcSEcCtD
Nedocromil—Influenza—Rosuvastatin—atherosclerosis	0.00412	0.0115	CcSEcCtD
Nedocromil—Arthritis—Ezetimibe—atherosclerosis	0.00408	0.0114	CcSEcCtD
Nedocromil—Bronchitis—Rosuvastatin—atherosclerosis	0.00396	0.0111	CcSEcCtD
Nedocromil—Arthritis—Simvastatin—atherosclerosis	0.00389	0.0109	CcSEcCtD
Nedocromil—Eczema—Niacin—atherosclerosis	0.00386	0.0108	CcSEcCtD
Nedocromil—HSP90AA1—liver—atherosclerosis	0.00362	0.0421	CbGeAlD
Nedocromil—Arthritis—Niacin—atherosclerosis	0.00357	0.00999	CcSEcCtD
Nedocromil—Arthritis—Pravastatin—atherosclerosis	0.00352	0.00984	CcSEcCtD
Nedocromil—Influenza—Lovastatin—atherosclerosis	0.00349	0.00977	CcSEcCtD
Nedocromil—Eosinophilia—Lovastatin—atherosclerosis	0.00346	0.00967	CcSEcCtD
Nedocromil—Sinusitis—Rosuvastatin—atherosclerosis	0.00345	0.00964	CcSEcCtD
Nedocromil—Influenza—Ezetimibe—atherosclerosis	0.00343	0.00958	CcSEcCtD
Nedocromil—Eosinophilia—Ezetimibe—atherosclerosis	0.00339	0.00949	CcSEcCtD
Nedocromil—Rhinitis—Rosuvastatin—atherosclerosis	0.00331	0.00925	CcSEcCtD
Nedocromil—Pharyngitis—Rosuvastatin—atherosclerosis	0.00327	0.00916	CcSEcCtD
Nedocromil—Eosinophilia—Simvastatin—atherosclerosis	0.00324	0.00905	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00318	0.00891	CcSEcCtD
Nedocromil—Bronchitis—Simvastatin—atherosclerosis	0.00314	0.00879	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00304	0.00849	CcSEcCtD
Nedocromil—Influenza—Niacin—atherosclerosis	0.003	0.00839	CcSEcCtD
Nedocromil—Influenza—Pravastatin—atherosclerosis	0.00295	0.00826	CcSEcCtD
Nedocromil—Eosinophilia—Pravastatin—atherosclerosis	0.00292	0.00818	CcSEcCtD
Nedocromil—Sinusitis—Lovastatin—atherosclerosis	0.00292	0.00817	CcSEcCtD
Nedocromil—Bronchitis—Niacin—atherosclerosis	0.00289	0.00807	CcSEcCtD
Nedocromil—Sinusitis—Ezetimibe—atherosclerosis	0.00287	0.00802	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00275	0.00768	CcSEcCtD
Nedocromil—Sinusitis—Simvastatin—atherosclerosis	0.00273	0.00764	CcSEcCtD
Nedocromil—Pharyngitis—Ezetimibe—atherosclerosis	0.00272	0.00761	CcSEcCtD
Nedocromil—Cough—Rosuvastatin—atherosclerosis	0.00251	0.00701	CcSEcCtD
Nedocromil—Sinusitis—Pravastatin—atherosclerosis	0.00247	0.00691	CcSEcCtD
Nedocromil—Rhinitis—Niacin—atherosclerosis	0.00241	0.00673	CcSEcCtD
Nedocromil—Dysgeusia—Lovastatin—atherosclerosis	0.00238	0.00667	CcSEcCtD
Nedocromil—Rhinitis—Pravastatin—atherosclerosis	0.00237	0.00663	CcSEcCtD
Nedocromil—Pharyngitis—Pravastatin—atherosclerosis	0.00235	0.00656	CcSEcCtD
Nedocromil—Visual impairment—Niacin—atherosclerosis	0.00231	0.00647	CcSEcCtD
Nedocromil—Tremor—Lovastatin—atherosclerosis	0.00228	0.00638	CcSEcCtD
Nedocromil—Visual impairment—Pravastatin—atherosclerosis	0.00228	0.00637	CcSEcCtD
Nedocromil—Dysgeusia—Simvastatin—atherosclerosis	0.00223	0.00624	CcSEcCtD
Nedocromil—Leukopenia—Lovastatin—atherosclerosis	0.00218	0.00609	CcSEcCtD
Nedocromil—Tremor—Simvastatin—atherosclerosis	0.00213	0.00597	CcSEcCtD
Nedocromil—Cough—Ezetimibe—atherosclerosis	0.00208	0.00583	CcSEcCtD
Nedocromil—Chest pain—Lovastatin—atherosclerosis	0.00207	0.0058	CcSEcCtD
Nedocromil—Dyspepsia—Rosuvastatin—atherosclerosis	0.00206	0.00577	CcSEcCtD
Nedocromil—Leukopenia—Simvastatin—atherosclerosis	0.00204	0.0057	CcSEcCtD
Nedocromil—Chest pain—Ezetimibe—atherosclerosis	0.00203	0.00568	CcSEcCtD
Nedocromil—Dry mouth—Lovastatin—atherosclerosis	0.00203	0.00567	CcSEcCtD
Nedocromil—Dysgeusia—Pravastatin—atherosclerosis	0.00202	0.00564	CcSEcCtD
Nedocromil—Pain—Rosuvastatin—atherosclerosis	0.002	0.00561	CcSEcCtD
Nedocromil—Dry mouth—Ezetimibe—atherosclerosis	0.00199	0.00556	CcSEcCtD
Nedocromil—Anaphylactic shock—Lovastatin—atherosclerosis	0.00199	0.00556	CcSEcCtD
Nedocromil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00195	0.00545	CcSEcCtD
Nedocromil—Chest pain—Simvastatin—atherosclerosis	0.00194	0.00542	CcSEcCtD
Nedocromil—Tremor—Pravastatin—atherosclerosis	0.00193	0.00539	CcSEcCtD
Nedocromil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00192	0.00536	CcSEcCtD
Nedocromil—Leukopenia—Niacin—atherosclerosis	0.00187	0.00523	CcSEcCtD
Nedocromil—Urticaria—Rosuvastatin—atherosclerosis	0.00186	0.00521	CcSEcCtD
Nedocromil—Anaphylactic shock—Simvastatin—atherosclerosis	0.00186	0.0052	CcSEcCtD
Nedocromil—Abdominal pain—Rosuvastatin—atherosclerosis	0.00185	0.00518	CcSEcCtD
Nedocromil—Leukopenia—Pravastatin—atherosclerosis	0.00184	0.00515	CcSEcCtD
Nedocromil—Cough—Niacin—atherosclerosis	0.00182	0.0051	CcSEcCtD
Nedocromil—Cough—Pravastatin—atherosclerosis	0.0018	0.00502	CcSEcCtD
Nedocromil—Dyspnoea—Lovastatin—atherosclerosis	0.00177	0.00495	CcSEcCtD
Nedocromil—Chest pain—Pravastatin—atherosclerosis	0.00175	0.0049	CcSEcCtD
Nedocromil—Dyspepsia—Lovastatin—atherosclerosis	0.00175	0.00489	CcSEcCtD
Nedocromil—Dry mouth—Niacin—atherosclerosis	0.00174	0.00487	CcSEcCtD
Nedocromil—Dyspnoea—Ezetimibe—atherosclerosis	0.00174	0.00486	CcSEcCtD
Nedocromil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00173	0.00483	CcSEcCtD
Nedocromil—Dyspepsia—Ezetimibe—atherosclerosis	0.00172	0.0048	CcSEcCtD
Nedocromil—Fatigue—Lovastatin—atherosclerosis	0.00171	0.00479	CcSEcCtD
Nedocromil—Anaphylactic shock—Niacin—atherosclerosis	0.00171	0.00477	CcSEcCtD
Nedocromil—Pain—Lovastatin—atherosclerosis	0.0017	0.00475	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00168	0.0047	CcSEcCtD
Nedocromil—Asthenia—Rosuvastatin—atherosclerosis	0.00168	0.0047	CcSEcCtD
Nedocromil—Anaphylactic shock—Pravastatin—atherosclerosis	0.00168	0.0047	CcSEcCtD
Nedocromil—Fatigue—Ezetimibe—atherosclerosis	0.00168	0.0047	CcSEcCtD
Nedocromil—Pain—Ezetimibe—atherosclerosis	0.00167	0.00466	CcSEcCtD
Nedocromil—Dyspnoea—Simvastatin—atherosclerosis	0.00166	0.00463	CcSEcCtD
Nedocromil—Dyspepsia—Simvastatin—atherosclerosis	0.00164	0.00457	CcSEcCtD
Nedocromil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00162	0.00454	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0016	0.00449	CcSEcCtD
Nedocromil—Diarrhoea—Rosuvastatin—atherosclerosis	0.0016	0.00449	CcSEcCtD
Nedocromil—Fatigue—Simvastatin—atherosclerosis	0.0016	0.00448	CcSEcCtD
Nedocromil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00159	0.00446	CcSEcCtD
Nedocromil—Pain—Simvastatin—atherosclerosis	0.00159	0.00444	CcSEcCtD
Nedocromil—Urticaria—Lovastatin—atherosclerosis	0.00158	0.00441	CcSEcCtD
Nedocromil—Body temperature increased—Lovastatin—atherosclerosis	0.00157	0.00439	CcSEcCtD
Nedocromil—Abdominal pain—Lovastatin—atherosclerosis	0.00157	0.00439	CcSEcCtD
Nedocromil—Dizziness—Rosuvastatin—atherosclerosis	0.00155	0.00434	CcSEcCtD
Nedocromil—Urticaria—Ezetimibe—atherosclerosis	0.00155	0.00433	CcSEcCtD
Nedocromil—Abdominal pain—Ezetimibe—atherosclerosis	0.00154	0.00431	CcSEcCtD
Nedocromil—Body temperature increased—Ezetimibe—atherosclerosis	0.00154	0.00431	CcSEcCtD
Nedocromil—Dyspnoea—Niacin—atherosclerosis	0.00152	0.00425	CcSEcCtD
Nedocromil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00152	0.00425	CcSEcCtD
Nedocromil—Dyspepsia—Niacin—atherosclerosis	0.0015	0.0042	CcSEcCtD
Nedocromil—Dyspnoea—Pravastatin—atherosclerosis	0.0015	0.00419	CcSEcCtD
Nedocromil—Dyspepsia—Pravastatin—atherosclerosis	0.00148	0.00414	CcSEcCtD
Nedocromil—Rash—Rosuvastatin—atherosclerosis	0.00148	0.00413	CcSEcCtD
Nedocromil—Dermatitis—Rosuvastatin—atherosclerosis	0.00148	0.00413	CcSEcCtD
Nedocromil—Urticaria—Simvastatin—atherosclerosis	0.00148	0.00413	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Niacin—atherosclerosis	0.00147	0.00412	CcSEcCtD
Nedocromil—Body temperature increased—Simvastatin—atherosclerosis	0.00147	0.00411	CcSEcCtD
Nedocromil—Abdominal pain—Simvastatin—atherosclerosis	0.00147	0.00411	CcSEcCtD
Nedocromil—Headache—Rosuvastatin—atherosclerosis	0.00147	0.00411	CcSEcCtD
Nedocromil—Hypersensitivity—Lovastatin—atherosclerosis	0.00146	0.00409	CcSEcCtD
Nedocromil—Pain—Niacin—atherosclerosis	0.00146	0.00408	CcSEcCtD
Nedocromil—Fatigue—Pravastatin—atherosclerosis	0.00145	0.00405	CcSEcCtD
Nedocromil—Pain—Pravastatin—atherosclerosis	0.00144	0.00402	CcSEcCtD
Nedocromil—Hypersensitivity—Ezetimibe—atherosclerosis	0.00144	0.00401	CcSEcCtD
Nedocromil—Asthenia—Lovastatin—atherosclerosis	0.00143	0.00399	CcSEcCtD
Nedocromil—Asthenia—Ezetimibe—atherosclerosis	0.0014	0.00391	CcSEcCtD
Nedocromil—Gastrointestinal pain—Niacin—atherosclerosis	0.0014	0.0039	CcSEcCtD
Nedocromil—Nausea—Rosuvastatin—atherosclerosis	0.00139	0.00389	CcSEcCtD
Nedocromil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00137	0.00384	CcSEcCtD
Nedocromil—Hypersensitivity—Simvastatin—atherosclerosis	0.00137	0.00383	CcSEcCtD
Nedocromil—Diarrhoea—Lovastatin—atherosclerosis	0.00136	0.0038	CcSEcCtD
Nedocromil—Urticaria—Niacin—atherosclerosis	0.00136	0.00379	CcSEcCtD
Nedocromil—Abdominal pain—Niacin—atherosclerosis	0.00135	0.00377	CcSEcCtD
Nedocromil—Body temperature increased—Niacin—atherosclerosis	0.00135	0.00377	CcSEcCtD
Nedocromil—Urticaria—Pravastatin—atherosclerosis	0.00133	0.00373	CcSEcCtD
Nedocromil—Asthenia—Simvastatin—atherosclerosis	0.00133	0.00373	CcSEcCtD
Nedocromil—Diarrhoea—Ezetimibe—atherosclerosis	0.00133	0.00373	CcSEcCtD
Nedocromil—Body temperature increased—Pravastatin—atherosclerosis	0.00133	0.00371	CcSEcCtD
Nedocromil—Abdominal pain—Pravastatin—atherosclerosis	0.00133	0.00371	CcSEcCtD
Nedocromil—Dizziness—Lovastatin—atherosclerosis	0.00131	0.00367	CcSEcCtD
Nedocromil—Dizziness—Ezetimibe—atherosclerosis	0.00129	0.0036	CcSEcCtD
Nedocromil—Diarrhoea—Simvastatin—atherosclerosis	0.00127	0.00356	CcSEcCtD
Nedocromil—Vomiting—Lovastatin—atherosclerosis	0.00126	0.00353	CcSEcCtD
Nedocromil—Hypersensitivity—Niacin—atherosclerosis	0.00126	0.00352	CcSEcCtD
Nedocromil—Rash—Lovastatin—atherosclerosis	0.00125	0.0035	CcSEcCtD
Nedocromil—Dermatitis—Lovastatin—atherosclerosis	0.00125	0.0035	CcSEcCtD
Nedocromil—Headache—Lovastatin—atherosclerosis	0.00124	0.00348	CcSEcCtD
Nedocromil—Vomiting—Ezetimibe—atherosclerosis	0.00124	0.00346	CcSEcCtD
Nedocromil—Hypersensitivity—Pravastatin—atherosclerosis	0.00124	0.00346	CcSEcCtD
Nedocromil—Dizziness—Simvastatin—atherosclerosis	0.00123	0.00344	CcSEcCtD
Nedocromil—Rash—Ezetimibe—atherosclerosis	0.00123	0.00344	CcSEcCtD
Nedocromil—Dermatitis—Ezetimibe—atherosclerosis	0.00123	0.00343	CcSEcCtD
Nedocromil—Asthenia—Niacin—atherosclerosis	0.00122	0.00342	CcSEcCtD
Nedocromil—Headache—Ezetimibe—atherosclerosis	0.00122	0.00341	CcSEcCtD
Nedocromil—Asthenia—Pravastatin—atherosclerosis	0.00121	0.00337	CcSEcCtD
Nedocromil—Vomiting—Simvastatin—atherosclerosis	0.00118	0.0033	CcSEcCtD
Nedocromil—Nausea—Lovastatin—atherosclerosis	0.00118	0.0033	CcSEcCtD
Nedocromil—Rash—Simvastatin—atherosclerosis	0.00117	0.00328	CcSEcCtD
Nedocromil—Dermatitis—Simvastatin—atherosclerosis	0.00117	0.00327	CcSEcCtD
Nedocromil—Diarrhoea—Niacin—atherosclerosis	0.00117	0.00326	CcSEcCtD
Nedocromil—Headache—Simvastatin—atherosclerosis	0.00116	0.00326	CcSEcCtD
Nedocromil—Nausea—Ezetimibe—atherosclerosis	0.00116	0.00324	CcSEcCtD
Nedocromil—Diarrhoea—Pravastatin—atherosclerosis	0.00115	0.00321	CcSEcCtD
Nedocromil—Dizziness—Niacin—atherosclerosis	0.00113	0.00316	CcSEcCtD
Nedocromil—Dizziness—Pravastatin—atherosclerosis	0.00111	0.00311	CcSEcCtD
Nedocromil—Nausea—Simvastatin—atherosclerosis	0.0011	0.00309	CcSEcCtD
Nedocromil—Vomiting—Niacin—atherosclerosis	0.00108	0.00303	CcSEcCtD
Nedocromil—Rash—Niacin—atherosclerosis	0.00108	0.00301	CcSEcCtD
Nedocromil—Dermatitis—Niacin—atherosclerosis	0.00107	0.00301	CcSEcCtD
Nedocromil—Headache—Niacin—atherosclerosis	0.00107	0.00299	CcSEcCtD
Nedocromil—Vomiting—Pravastatin—atherosclerosis	0.00107	0.00299	CcSEcCtD
Nedocromil—Rash—Pravastatin—atherosclerosis	0.00106	0.00296	CcSEcCtD
Nedocromil—Dermatitis—Pravastatin—atherosclerosis	0.00106	0.00296	CcSEcCtD
Nedocromil—Headache—Pravastatin—atherosclerosis	0.00105	0.00294	CcSEcCtD
Nedocromil—Nausea—Niacin—atherosclerosis	0.00101	0.00283	CcSEcCtD
Nedocromil—Nausea—Pravastatin—atherosclerosis	0.000998	0.00279	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—APOC3—atherosclerosis	0.00012	0.000216	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PARP1—atherosclerosis	0.00012	0.000215	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GHRL—atherosclerosis	0.00012	0.000215	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PLAT—atherosclerosis	0.00012	0.000215	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CX3CL1—atherosclerosis	0.00012	0.000215	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—atherosclerosis	0.000119	0.000215	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CG—atherosclerosis	0.000119	0.000215	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—LDLR—atherosclerosis	0.000119	0.000214	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—MAPK3—atherosclerosis	0.000118	0.000213	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—atherosclerosis	0.000117	0.000211	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SPP1—atherosclerosis	0.000117	0.000211	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—INS—atherosclerosis	0.000117	0.00021	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCL8—atherosclerosis	0.000117	0.00021	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CETP—atherosclerosis	0.000117	0.000209	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL2—atherosclerosis	0.000115	0.000207	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—F2—atherosclerosis	0.000115	0.000207	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—MAPK3—atherosclerosis	0.000114	0.000206	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD14—atherosclerosis	0.000114	0.000205	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CNR2—atherosclerosis	0.000113	0.000204	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IGF1—atherosclerosis	0.000113	0.000203	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—INS—atherosclerosis	0.000113	0.000203	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SCARB1—atherosclerosis	0.000112	0.000201	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL2—atherosclerosis	0.000111	0.0002	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MAPK3—atherosclerosis	0.000111	0.0002	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—VCAM1—atherosclerosis	0.00011	0.000198	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CG—atherosclerosis	0.00011	0.000198	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF1—atherosclerosis	0.000109	0.000197	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PDGFB—atherosclerosis	0.000109	0.000195	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SERPINE1—atherosclerosis	0.000108	0.000193	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SOCS3—atherosclerosis	0.000107	0.000192	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AGT—atherosclerosis	0.000106	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMGCR—atherosclerosis	0.000105	0.000189	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KNG1—atherosclerosis	0.000105	0.000189	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGTR1—atherosclerosis	0.000104	0.000188	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SERPINE1—atherosclerosis	0.000104	0.000187	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—LEP—atherosclerosis	0.000104	0.000187	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APOE—atherosclerosis	0.000104	0.000187	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CAV1—atherosclerosis	0.000103	0.000185	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOS3—atherosclerosis	0.000103	0.000184	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APOA1—atherosclerosis	0.000103	0.000184	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL2—atherosclerosis	0.000102	0.000184	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PLG—atherosclerosis	0.000102	0.000183	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VWF—atherosclerosis	0.000101	0.000182	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOC3—atherosclerosis	0.0001	0.00018	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LDLR—atherosclerosis	9.98e-05	0.000179	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ESR1—atherosclerosis	9.91e-05	0.000178	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOS3—atherosclerosis	9.91e-05	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—F2—atherosclerosis	9.79e-05	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL18—atherosclerosis	9.75e-05	0.000175	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL3—atherosclerosis	9.74e-05	0.000175	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD40LG—atherosclerosis	9.71e-05	0.000175	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SOCS3—atherosclerosis	9.63e-05	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—atherosclerosis	9.57e-05	0.000172	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCA1—atherosclerosis	9.39e-05	0.000169	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CG—atherosclerosis	9.37e-05	0.000168	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AGER—atherosclerosis	9.36e-05	0.000168	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP9—atherosclerosis	9.34e-05	0.000168	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NCF1—atherosclerosis	9.33e-05	0.000168	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP3—atherosclerosis	9.3e-05	0.000167	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKCG—atherosclerosis	9.27e-05	0.000167	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF2—atherosclerosis	9.26e-05	0.000166	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NFKB1—atherosclerosis	9.24e-05	0.000166	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOB—atherosclerosis	9.22e-05	0.000166	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL8—atherosclerosis	9.1e-05	0.000164	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD36—atherosclerosis	9.06e-05	0.000163	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOB—atherosclerosis	8.99e-05	0.000162	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—MAPK3—atherosclerosis	8.97e-05	0.000161	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL8—atherosclerosis	8.92e-05	0.00016	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—INS—atherosclerosis	8.87e-05	0.000159	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EDN1—atherosclerosis	8.85e-05	0.000159	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCR2—atherosclerosis	8.81e-05	0.000158	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EDNRA—atherosclerosis	8.81e-05	0.000158	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—LPL—atherosclerosis	8.8e-05	0.000158	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—atherosclerosis	8.8e-05	0.000158	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL8—atherosclerosis	8.79e-05	0.000158	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL5—atherosclerosis	8.78e-05	0.000158	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CYBA—atherosclerosis	8.77e-05	0.000158	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL2—atherosclerosis	8.73e-05	0.000157	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—atherosclerosis	8.66e-05	0.000156	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GHRL—atherosclerosis	8.59e-05	0.000154	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLAT—atherosclerosis	8.59e-05	0.000154	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PARP1—atherosclerosis	8.59e-05	0.000154	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LPL—atherosclerosis	8.59e-05	0.000154	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1—atherosclerosis	8.58e-05	0.000154	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PRKCG—atherosclerosis	8.56e-05	0.000154	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—atherosclerosis	8.49e-05	0.000153	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—atherosclerosis	8.38e-05	0.000151	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—atherosclerosis	8.36e-05	0.00015	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PDGFB—atherosclerosis	8.35e-05	0.00015	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKCG—atherosclerosis	8.35e-05	0.00015	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—STAT3—atherosclerosis	8.3e-05	0.000149	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—atherosclerosis	8.24e-05	0.000148	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	8.21e-05	0.000148	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CRP—atherosclerosis	8.17e-05	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—NFKB1—atherosclerosis	8.16e-05	0.000147	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SERPINE1—atherosclerosis	8.15e-05	0.000146	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NFKB1—atherosclerosis	8.15e-05	0.000146	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SPP1—atherosclerosis	8.13e-05	0.000146	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—atherosclerosis	8.13e-05	0.000146	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL8—atherosclerosis	8.1e-05	0.000146	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—atherosclerosis	8.06e-05	0.000145	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK8—atherosclerosis	8.02e-05	0.000144	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK8—atherosclerosis	8.01e-05	0.000144	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—atherosclerosis	7.99e-05	0.000144	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—atherosclerosis	7.95e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MAPK3—atherosclerosis	7.93e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTHFR—atherosclerosis	7.92e-05	0.000142	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NFKB1—atherosclerosis	7.87e-05	0.000141	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TLR4—atherosclerosis	7.83e-05	0.000141	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—atherosclerosis	7.78e-05	0.00014	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK8—atherosclerosis	7.74e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOB—atherosclerosis	7.72e-05	0.000139	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—atherosclerosis	7.71e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PDGFB—atherosclerosis	7.71e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—atherosclerosis	7.7e-05	0.000138	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KNG1—atherosclerosis	7.54e-05	0.000135	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDGFB—atherosclerosis	7.52e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTM1—atherosclerosis	7.51e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ICAM1—atherosclerosis	7.51e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGTR1—atherosclerosis	7.49e-05	0.000135	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—atherosclerosis	7.39e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOE—atherosclerosis	7.38e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—LPL—atherosclerosis	7.37e-05	0.000132	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGT—atherosclerosis	7.35e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MAPK3—atherosclerosis	7.34e-05	0.000132	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT3—atherosclerosis	7.32e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CAV1—atherosclerosis	7.31e-05	0.000131	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLG—atherosclerosis	7.3e-05	0.000131	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOA1—atherosclerosis	7.29e-05	0.000131	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOE—atherosclerosis	7.2e-05	0.000129	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LEP—atherosclerosis	7.2e-05	0.000129	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—atherosclerosis	7.19e-05	0.000129	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—atherosclerosis	7.19e-05	0.000129	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—atherosclerosis	7.14e-05	0.000128	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CAV1—atherosclerosis	7.13e-05	0.000128	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOA1—atherosclerosis	7.11e-05	0.000128	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT3—atherosclerosis	7.07e-05	0.000127	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK3—atherosclerosis	7e-05	0.000126	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CD36—atherosclerosis	7e-05	0.000126	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK3—atherosclerosis	7e-05	0.000126	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SOCS3—atherosclerosis	6.91e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL8—atherosclerosis	6.9e-05	0.000124	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS2—atherosclerosis	6.87e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ESR1—atherosclerosis	6.87e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—F2—atherosclerosis	6.79e-05	0.000122	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—atherosclerosis	6.79e-05	0.000122	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK3—atherosclerosis	6.76e-05	0.000121	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP3—atherosclerosis	6.68e-05	0.00012	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—atherosclerosis	6.67e-05	0.00012	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF2—atherosclerosis	6.65e-05	0.00012	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MTHFR—atherosclerosis	6.64e-05	0.000119	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—atherosclerosis	6.56e-05	0.000118	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—atherosclerosis	6.56e-05	0.000118	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARA—atherosclerosis	6.51e-05	0.000117	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CG—atherosclerosis	6.5e-05	0.000117	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOB—atherosclerosis	6.45e-05	0.000116	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EDN1—atherosclerosis	6.35e-05	0.000114	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AGT—atherosclerosis	6.31e-05	0.000113	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL5—atherosclerosis	6.3e-05	0.000113	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—INS—atherosclerosis	6.3e-05	0.000113	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—atherosclerosis	6.24e-05	0.000112	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—MAPK3—atherosclerosis	6.22e-05	0.000112	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOE—atherosclerosis	6.18e-05	0.000111	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NFKB1—atherosclerosis	6.17e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LPL—atherosclerosis	6.16e-05	0.000111	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—INS—atherosclerosis	6.15e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAV1—atherosclerosis	6.12e-05	0.00011	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOA1—atherosclerosis	6.11e-05	0.00011	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK8—atherosclerosis	6.07e-05	0.000109	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—atherosclerosis	6.05e-05	0.000109	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL2—atherosclerosis	6.05e-05	0.000109	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCG—atherosclerosis	5.99e-05	0.000108	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1—atherosclerosis	5.95e-05	0.000107	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SPP1—atherosclerosis	5.84e-05	0.000105	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—atherosclerosis	5.8e-05	0.000104	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SERPINE1—atherosclerosis	5.79e-05	0.000104	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNG—atherosclerosis	5.71e-05	0.000103	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SERPINE1—atherosclerosis	5.65e-05	0.000102	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—atherosclerosis	5.6e-05	0.000101	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CG—atherosclerosis	5.58e-05	0.0001	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT3—atherosclerosis	5.55e-05	9.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—atherosclerosis	5.53e-05	9.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDGFB—atherosclerosis	5.4e-05	9.71e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—atherosclerosis	5.39e-05	9.69e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—atherosclerosis	5.38e-05	9.67e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—atherosclerosis	5.35e-05	9.62e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK3—atherosclerosis	5.3e-05	9.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—INS—atherosclerosis	5.28e-05	9.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGT—atherosclerosis	5.27e-05	9.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOE—atherosclerosis	5.17e-05	9.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LEP—atherosclerosis	5.17e-05	9.29e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—atherosclerosis	5.14e-05	9.25e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—atherosclerosis	5.12e-05	9.2e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CAV1—atherosclerosis	5.12e-05	9.2e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—atherosclerosis	5.11e-05	9.19e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOA1—atherosclerosis	5.11e-05	9.18e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—atherosclerosis	5.09e-05	9.16e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—atherosclerosis	5.05e-05	9.09e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—atherosclerosis	4.94e-05	8.88e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ESR1—atherosclerosis	4.93e-05	8.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—F2—atherosclerosis	4.87e-05	8.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—atherosclerosis	4.84e-05	8.7e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL8—atherosclerosis	4.78e-05	8.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NFKB1—atherosclerosis	4.75e-05	8.54e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—atherosclerosis	4.72e-05	8.49e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—atherosclerosis	4.72e-05	8.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK8—atherosclerosis	4.67e-05	8.4e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CG—atherosclerosis	4.66e-05	8.38e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—atherosclerosis	4.63e-05	8.32e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—atherosclerosis	4.62e-05	8.3e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—atherosclerosis	4.56e-05	8.19e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—atherosclerosis	4.55e-05	8.17e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—INS—atherosclerosis	4.41e-05	7.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL2—atherosclerosis	4.34e-05	7.8e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—atherosclerosis	4.33e-05	7.78e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NFKB1—atherosclerosis	4.28e-05	7.69e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STAT3—atherosclerosis	4.27e-05	7.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1—atherosclerosis	4.27e-05	7.67e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—atherosclerosis	4.23e-05	7.61e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK8—atherosclerosis	4.21e-05	7.56e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—atherosclerosis	4.2e-05	7.54e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK3—atherosclerosis	4.08e-05	7.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SERPINE1—atherosclerosis	4.05e-05	7.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STAT3—atherosclerosis	3.94e-05	7.09e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—atherosclerosis	3.88e-05	6.98e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—atherosclerosis	3.88e-05	6.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—atherosclerosis	3.87e-05	6.96e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT3—atherosclerosis	3.85e-05	6.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAPK3—atherosclerosis	3.77e-05	6.77e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK3—atherosclerosis	3.67e-05	6.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—atherosclerosis	3.65e-05	6.57e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—atherosclerosis	3.58e-05	6.43e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—atherosclerosis	3.57e-05	6.41e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL8—atherosclerosis	3.43e-05	6.17e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—atherosclerosis	3.11e-05	5.58e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NFKB1—atherosclerosis	3.07e-05	5.52e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK8—atherosclerosis	3.02e-05	5.43e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—atherosclerosis	2.98e-05	5.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—atherosclerosis	2.79e-05	5.01e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT3—atherosclerosis	2.76e-05	4.96e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—atherosclerosis	2.75e-05	4.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—atherosclerosis	2.75e-05	4.95e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—atherosclerosis	2.69e-05	4.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK3—atherosclerosis	2.64e-05	4.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—atherosclerosis	2.56e-05	4.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—atherosclerosis	2.54e-05	4.57e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—atherosclerosis	2.48e-05	4.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—atherosclerosis	2.13e-05	3.82e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—atherosclerosis	1.93e-05	3.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—atherosclerosis	1.78e-05	3.2e-05	CbGpPWpGaD
